Biotechnology
Sort by: Featured Most recent Most read Most commented
75 results total, viewing 41 - 50
Chamber meet focuses on innovation, collaboration
The 2012 meeting of the Greater Providence Chamber of Commerce, held Monday at the R.I. Convention Center, made news that could re-shape the region’s economy. more
| 11/20/12
Covidien brain monitor earns nod from NICE
Covidien PLC’s BIS Brain Monitoring System earned a recommendation from the U.K.-based National Institute for health and Clinical Excellence. more
| 11/23/12
URI looking to expand Providence presence
The University of Rhode Island plans to increase its presence in the state’s capital city, according to President David M. Dooley, as part of a strategy to better prepare its students for success as well as help Rhode Island’s economy grow out of the hole it is in. more
| 11/28/12
UMass Dartmouth professor lands $400K for cell imaging research
Maolin Guo, associate professor of chemistry and biochemistry at the University of Massachusetts Dartmouth, landed a $400,000 research grant from the National Science Foundation to support the development of a molecular imaging probe for cell research. more
| 12/3/12
UMass Dartmouth completes first stage of MAB construction
Seven months after the initial groundbreaking, the University of Massachusetts Dartmouth celebrated the end of the first stage of construction of the Massachusetts Accelerator for Biomanufacturing with a “topping off ceremony” on Thursday in Fall River. more
| 12/7/12
R.I. to receive $648K in Pfizer settlement
Rhode Island is set to receive $647,722 as part of a $42.9 million national settlement with drug maker Pfizer Inc. for the unlawful promotion of its drugs Zyvox and Lyrica. more
| 12/12/12
Amgen tops profit estimates on sales of arthritis, bone drugs
Amgen Inc., one of the world’s largest biotechnology companies, reported fourth-quarter profit that beat analyst estimates as sales of arthritis and bone drugs rose. more
Amgen $150M Aranesp misbranding plea deal approved
(Updated, 10:45 a.m.) A federal judge accepted Amgen Inc.’s plea agreement on a charge that it misbranded its anemia drug Aranesp, putting to rest a five-year probe of the company’s marketing practices. more
Covidien to acquire CV Ingenuity
Medical device maker Covidien PLC has signed a definitive agreement to acquire Freemont, Calif.-based CV Ingenuity during the first quarter of 2013, the company announced Wednesday. more
| 12/26/12
EpiVax, partners move ahead on H7N9 flu vaccine production
New recipes for a vaccine to combat the H7N9 flu went into production this weekend, in a collaboration between EpiVax and Aldevron in Fargo, N.D., and a researcher at Fort Detrick, Md., the home of the Army Medical Research Institute of Infectious Diseases, according to Dr. Anne S. De Groot. more
« Prev | 1 … 2 | 3 | 4 | 5 | 6 | 7 | 8 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News